
InMed Pharmaceuticals Inc.
INMHealthcare|Drug Manufacturers - Specialty & Generic|CA
$15.56
+2.35 (+17.79%)
Cash / Share
$2074.83
Next Earnings Report
Feb 16, 2027
EPS est. -$944.44 · Revenue est. $300.0K
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Oct 28, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics
Nov 6, 2026 · PRNewsWire
InMed Announces Expected Closing of Merger and Commencement of Trading on Nasdaq Under the Name "Mentari Therapeutics, Inc." and Ticker Symbol "MTRI"
Nov 5, 2026 · Newsfile Corp
InMed Announces Results of 2026 Annual General and Special Meeting, Approval of Corporate Name Change and Completion of Share Consolidation
Nov 4, 2026 · Newsfile Corp
InMed Reports First Quarter Fiscal 2027 Financial Results and Provides Corporate Update
Nov 3, 2026 · Newsfile Corp
InMed Announces Share Consolidation in Connection with Proposed Merger
Nov 2, 2026 · Newsfile Corp
InMed Announces CVR Distribution Record Date in Connection with Proposed Merger
Oct 26, 2026 · Newsfile Corp
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Shareholders' Equity Compliance
Sep 18, 2026 · Newsfile Corp
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update
Sep 9, 2026 · Newsfile Corp
SEC Filings (96)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 3, 2026 | 8-K | Material event | DocumentIndex |
| Nov 3, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 2, 2026 | 425 | DocumentIndex | |
| Oct 28, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 27, 2026 | 425 | DocumentIndex | |
| Oct 7, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 1, 2026 | EFFECT | DocumentIndex | |
| Oct 1, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 29, 2026 | S-4/A | DocumentIndex | |
| Sep 18, 2026 | 8-K | Material event | DocumentIndex |
| Sep 9, 2026 | S-4/A | DocumentIndex | |
| Sep 9, 2026 | 425 | DocumentIndex | |
| Sep 9, 2026 | 10-K | Annual report | DocumentIndex |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 22, 2026 | 425 | DocumentIndex | |
| Jul 22, 2026 | 425 | DocumentIndex | |
| Jul 22, 2026 | 8-K | Material event | DocumentIndex |
| Jul 20, 2026 | 425 | DocumentIndex | |
| Jul 10, 2026 | 425 | DocumentIndex | |
| Jul 10, 2026 | 8-K | Material event | DocumentIndex |
| Jul 2, 2026 | S-4 | DocumentIndex | |
| Jun 10, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Jun 10, 2026 | 8-K | Material event | DocumentIndex |
| Jun 5, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 27, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 19, 2026 | 425 | DocumentIndex | |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| May 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 27, 2026 | 8-K | Material event | DocumentIndex |
| Apr 3, 2026 | 8-K | Material event | DocumentIndex |
| Apr 3, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 30, 2026 | EFFECT | DocumentIndex | |
| Mar 30, 2026 | 8-K | Material event | DocumentIndex |
| Mar 23, 2026 | 8-K | Material event | DocumentIndex |
| Mar 20, 2026 | S-3 | Shelf registration | DocumentIndex |
| Mar 9, 2026 | 8-K | Material event | DocumentIndex |